Full Text
The Full Text of this article is available as a PDF (73.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abbott A. What price the Olympian ideal? Nature. 2000 Sep 14;407(6801):124–127. doi: 10.1038/35025272. [DOI] [PubMed] [Google Scholar]
- Ashenden Michael J. A strategy to deter blood doping in sport. Haematologica. 2002 Mar;87(3):225–232. [PubMed] [Google Scholar]
- Booth F. W., Tseng B. S., Flück M., Carson J. A. Molecular and cellular adaptation of muscle in response to physical training. Acta Physiol Scand. 1998 Mar;162(3):343–350. doi: 10.1046/j.1365-201X.1998.0326e.x. [DOI] [PubMed] [Google Scholar]
- Brantigan C. O., Brantigan T. A., Joseph N. Effect of beta blockade and beta stimulation on stage fright. Am J Med. 1982 Jan;72(1):88–94. doi: 10.1016/0002-9343(82)90592-7. [DOI] [PubMed] [Google Scholar]
- Browne A., Lachance V., Pipe A. The ethics of blood testing as an element of doping control in sport. Med Sci Sports Exerc. 1999 Apr;31(4):497–501. doi: 10.1097/00005768-199904000-00001. [DOI] [PubMed] [Google Scholar]
- Catlin D. H., Hatton C. K. Use and abuse of anabolic and other drugs for athletic enhancement. Adv Intern Med. 1991;36:399–424. [PubMed] [Google Scholar]
- Catlin D. H., Murray T. H. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA. 1996 Jul 17;276(3):231–237. [PubMed] [Google Scholar]
- Cazzola M. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica. 2000 Jun;85(6):561–563. [PubMed] [Google Scholar]
- Fairbanks V. F., Tefferi A. Normal ranges for packed cell volume and hemoglobin concentration in adults: relevance to 'apparent polycythemia'. Eur J Haematol. 2000 Nov;65(5):285–296. doi: 10.1034/j.1600-0609.2000.065005285.x. [DOI] [PubMed] [Google Scholar]
- Hartgens Fred, Kuipers Harm. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513–554. doi: 10.2165/00007256-200434080-00003. [DOI] [PubMed] [Google Scholar]
- Maron B. J., Shirani J., Poliac L. C., Mathenge R., Roberts W. C., Mueller F. O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996 Jul 17;276(3):199–204. [PubMed] [Google Scholar]
- Russell Gabrielle, Gore Christopher J., Ashenden Michael J., Parisotto Robin, Hahn Allan G. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. Eur J Appl Physiol. 2002 Jan 11;86(5):442–449. doi: 10.1007/s00421-001-0560-6. [DOI] [PubMed] [Google Scholar]
- Schumacher Y. O., Grathwohl D., Barturen J. M., Wollenweber M., Heinrich L., Schmid A., Huber G., Keul J. Haemoglobin, haematocrit and red blood cell indices in elite cyclists. Are the control values for blood testing valid? Int J Sports Med. 2000 Jul;21(5):380–385. doi: 10.1055/s-2000-3785. [DOI] [PubMed] [Google Scholar]
- Wannamethee G., Perry I. J., Shaper A. G. Haematocrit, hypertension and risk of stroke. J Intern Med. 1994 Feb;235(2):163–168. doi: 10.1111/j.1365-2796.1994.tb01050.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
[Dutch translation]
brjsmed_38_6_666__index.html (1.3KB, html)
brjsmed_38_6_666__1.pdf (70KB, pdf)
brjsmed_38_6_666__2.pdf (31.5KB, pdf)